New Malaria Vaccines Offer a Real Shot at Fighting the Disease
Though homegrown malaria recently flared in the US, “there’s no high-income market for this product,” says Aurélia Nguyen, the chief program officer of Gavi, the Vaccine Alliance, which has made an initial commitment of $155 million to bring the new formulas to market and is beginning work on what it calls an African vaccine manufacturer […]
Read More